Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03702725
Title Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

multiple myeloma

Therapies

Dexamethasone + Ibrutinib + Lenalidomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.